Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)

Search Tenders

Pharmaceutical & Medical Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)

Receive Tenders like this by email

Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)

Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed) has been closed on 14 Sep 2022. It no longer accepts any bids. For further information, you can contact the National Institutes of Health

Bellow, you can find more information about this project:

Location: United States

General information

Donor:

National Institutes of Health

Industry:

Pharmaceutical & Medical

Status:

Closed

Timeline

Published:

10 May 2022

Deadline:

14 Sep 2022

Value:

Not available

Contacts

Name:

National Institutes of Health

Phone:

301-402-2541

Email: [email protected]

Description

https://www.grants.gov/grantsws/rest/opportunity/details 340231

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications focused on advancing development of vaccine candidates against Enterotoxigenic Escherichia coli (ETEC), Salmonella enterica serotype Paratyphi A, and two Shigella species, Shigella flexneri and S. sonnei.

Featured tenders